白三烯合成的抑制：哮喘的新疗法？ - Suppr | 超能文献

Inhibition of leukotriene synthesis: new therapy in asthma?

作者信息

Hui K P, Barnes N C

机构信息

Department of Medicine, National University of Singapore.

出版信息

Pulm Pharmacol. 1993 Mar;6(1):3-9. doi: 10.1006/pulp.1993.1002.

DOI:10.1006/pulp.1993.1002

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Inhibition of leukotriene synthesis: new therapy in asthma?白三烯合成的抑制：哮喘的新疗法？

Pulm Pharmacol. 1993 Mar;6(1):3-9. doi: 10.1006/pulp.1993.1002.

2

Pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors in the management of asthma.白三烯受体拮抗剂和5-脂氧合酶抑制剂在哮喘治疗中的药理学

Pharmacotherapy. 1997 Jan-Feb;17(1 Pt 2):22S-30S.

3

Recent advances in the search for novel 5-lipoxygenase inhibitors for the treatment of asthma.新型 5-脂氧合酶抑制剂治疗哮喘的研究进展。

Eur J Med Chem. 2018 Jun 10;153:65-72. doi: 10.1016/j.ejmech.2017.10.020. Epub 2017 Oct 10.

4

New frontiers in asthma therapy: leukotriene receptor antagonists and 5-lipoxygenase inhibitors. Introduction.

Pharmacotherapy. 1997 Jan-Feb;17(1 Pt 2):1S-2S.

5

Leukotriene-receptor antagonists and 5-lipoxygenase inhibitors in asthma.白三烯受体拮抗剂和5-脂氧合酶抑制剂在哮喘治疗中的应用

Ann Pharmacother. 1993 Jul-Aug;27(7-8):898-903. doi: 10.1177/106002809302700718.

6

Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part I: synthesis, receptors and role of leukotrienes in asthma.白三烯、白三烯受体拮抗剂及白三烯合成抑制剂在哮喘中的应用进展。第一部分：白三烯的合成、受体及其在哮喘中的作用

Pharmacol Res. 1999 Jul;40(1):3-13. doi: 10.1006/phrs.1998.0458.

7

Leukotrienes in respiratory disease.呼吸道疾病中的白三烯

Paediatr Respir Rev. 2001 Sep;2(3):238-44. doi: 10.1053/prrv.2001.0146.

8

Treatment of asthma with antileukotrienes: first line or last resort therapy?用抗白三烯药物治疗哮喘：一线治疗还是最后手段治疗？

Eur J Pharmacol. 2006 Mar 8;533(1-3):40-56. doi: 10.1016/j.ejphar.2005.12.070. Epub 2006 Feb 28.

9

Biosynthesis inhibitors for leukotrienes in bronchial asthma.支气管哮喘中白三烯的生物合成抑制剂

Allergol Immunopathol (Madr). 1997 Jul-Aug;25(4):209-16.

10

Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part II: clinical studies with leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma.白三烯、白三烯受体拮抗剂及白三烯合成抑制剂在哮喘中的应用：最新进展。第二部分：白三烯受体拮抗剂及白三烯合成抑制剂在哮喘中的临床研究

Pharmacol Res. 1999 Jul;40(1):15-29. doi: 10.1006/phrs.1998.0461.

引用本文的文献

1

Effect of a 5-lipoxygenase inhibitor, ZM 230487, on cutaneous allergic inflammation in the guinea-pig.5-脂氧合酶抑制剂ZM 230487对豚鼠皮肤过敏性炎症的影响。

Br J Pharmacol. 1994 Apr;111(4):1205-11. doi: 10.1111/j.1476-5381.1994.tb14873.x.

2

Intracellular (polymorphonuclear) magnesium content in patients with bronchial asthma between attacks.支气管哮喘发作间期患者的细胞内（多形核）镁含量

J R Soc Med. 1995 Aug;88(8):441-5.